These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30779679)

  • 21. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
    Int Forum Allergy Rhinol; 2019 Jan; 9(1):72-78. PubMed ID: 30179317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of childhood epistaxis with treatment of allergic rhinitis: a randomized controlled study.
    Teo WY; Wong HB; Hwarng GYH; Tan HKK
    Eur J Pediatr; 2023 Mar; 182(3):1127-1135. PubMed ID: 36595087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [EVALUATIONS OF SENSORY ATTRIBUTE OF INTRANASAL CORTICOSTEROID SPRAYS IN HEALTHY VOLUNTEERS].
    Watanabe T; Suzuki M
    Arerugi; 2018; 67(2):124-128. PubMed ID: 29553112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta-analysis.
    Sampieri G; Namavarian A; Lee JJW; Hamour AF; Lee JM
    Int Forum Allergy Rhinol; 2022 Jan; 12(1):11-27. PubMed ID: 34260153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
    Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
    Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local and systemic safety of intranasal corticosteroids.
    Sastre J; Mosges R
    J Investig Allergol Clin Immunol; 2012; 22(1):1-12. PubMed ID: 22448448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beclomethasone dipropionate hydrofluoroalkane for the treatment of allergic rhinitis.
    Ferrante G; Montalbano L; Cilluffo G; Malizia V; Marchese D; La Grutta S
    Expert Rev Clin Immunol; 2016; 12(3):279-88. PubMed ID: 26558604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical intranasal corticosteroids and growth velocity in children: a meta-analysis.
    Mener DJ; Shargorodsky J; Varadhan R; Lin SY
    Int Forum Allergy Rhinol; 2015 Feb; 5(2):95-103. PubMed ID: 25367369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
    Stanaland BE
    Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of intranasal corticosteroids in acute rhinosinusitis.
    Demoly P
    Am J Otolaryngol; 2008; 29(6):403-13. PubMed ID: 19144302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
    Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
    Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Medical Therapy in Allergic Rhinitis: A Systematic Review and Meta-Analysis.
    Zhang K; Li AR; Miglani A; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2022 Mar; 36(2):269-280. PubMed ID: 34546814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Anticholinergics for Treatment of Chronic Rhinitis: Systematic Review and Meta-Analysis.
    Pang JC; Vasudev M; Du AT; Nottoli MM; Dang K; Kuan EC
    Laryngoscope; 2023 Apr; 133(4):722-731. PubMed ID: 35838014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis.
    Phinyo P; Wongsa C; Sompornrattanaphan M; Thongngarm T
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):195-204. PubMed ID: 35278059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessments.
    Verkerk MM; Bhatia D; Rimmer J; Earls P; Sacks R; Harvey RJ
    Am J Rhinol Allergy; 2015; 29(1):3-18. PubMed ID: 25590306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.